These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38115117)

  • 1. Population ageing and sustainability of healthcare financing in China.
    Wu W; Long S; Cerda AA; Garcia LY; Jakovljevic M
    Cost Eff Resour Alloc; 2023 Dec; 21(1):97. PubMed ID: 38115117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.
    Wu J; Qiao J; Nicholas S; Liu Y; Maitland E
    BMC Health Serv Res; 2022 Sep; 22(1):1189. PubMed ID: 36138390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on the sustainability assessment of China's basic medical insurance fund under the background of population aging-evidence from Shanghai.
    Yu ZQ; Chen LP; Qu JQ; Wu WZ; Zeng Y
    Front Public Health; 2023; 11():1170782. PubMed ID: 37333524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the universal two-child policy on medical insurance funds with a rapidly ageing population: evidence from China's urban and rural residents' medical insurance.
    Zhang X; Huang J; Luo Y
    BMC Public Health; 2021 Jul; 21(1):1444. PubMed ID: 34294053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equity in health financing of Guangxi after China's universal health coverage: evidence based on health expenditure comparison in rural Guangxi Zhuang autonomous region from 2009 to 2013.
    Qin X; Luo H; Feng J; Li Y; Wei B; Feng Q
    Int J Equity Health; 2017 Sep; 16(1):174. PubMed ID: 28962656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research on Financing Mechanism of Long-Term Care Insurance in Xiamen, China: A System Dynamics Simulation.
    Zhang L; Fu S; Fang Y
    Front Public Health; 2021; 9():714044. PubMed ID: 34485237
    [No Abstract]   [Full Text] [Related]  

  • 8. Who pays for health care in China? The case of Heilongjiang province.
    Chen M; Zhao Y; Si L
    PLoS One; 2014; 9(10):e108867. PubMed ID: 25271768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research on the optimization of financing scheme of long-term care insurance in China based on system dynamics simulation.
    Zhang L; Fu S; Wang Y; Fang Y
    Front Public Health; 2022; 10():908864. PubMed ID: 36211654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Main characteristics and historical evolution of China' s health financing transition].
    Wang Q; Fu H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun; 56(3):462-470. PubMed ID: 38864132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New evidence on financing equity in China's health care reform--a case study on Gansu province, China.
    Chen M; Chen W; Zhao Y
    BMC Health Serv Res; 2012 Dec; 12():466. PubMed ID: 23244513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of population aging on balance of medical insurance funds in China.
    Qiu X; Zhao T; Kong Y; Chen F
    Int J Health Plann Manage; 2020 Jan; 35(1):152-161. PubMed ID: 31270860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A macro-view of China's elderly population: an analysis of the sampling survey in 1987 on China's population above 60 years of age.
    Tian X
    Chin J Popul Sci; 1989; 1(2):209-22. PubMed ID: 12284124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovation and financial sustainability in China's long-term care insurance: An empirical analysis of the Nantong pilot.
    Guo P; Li Y
    Front Public Health; 2022; 10():1024491. PubMed ID: 36504946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks.
    Fang EF; Xie C; Schenkel JA; Wu C; Long Q; Cui H; Aman Y; Frank J; Liao J; Zou H; Wang NY; Wu J; Liu X; Li T; Fang Y; Niu Z; Yang G; Hong J; Wang Q; Chen G; Li J; Chen HZ; Kang L; Su H; Gilmour BC; Zhu X; Jiang H; He N; Tao J; Leng SX; Tong T; Woo J
    Ageing Res Rev; 2020 Dec; 64():101174. PubMed ID: 32971255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engaging sub-national governments in addressing health equities: challenges and opportunities in China's health system reform.
    Brixi H; Mu Y; Targa B; Hipgrave D
    Health Policy Plan; 2013 Dec; 28(8):809-24. PubMed ID: 23221008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population ageing and health financing: A method for forecasting two sides of the same coin.
    Cylus J; Williams G; Carrino L; Roubal T; Barber S
    Health Policy; 2022 Dec; 126(12):1226-1232. PubMed ID: 36261302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in health expenditures in China in 2000s: has the health system reform improved affordability.
    Long Q; Xu L; Bekedam H; Tang S
    Int J Equity Health; 2013 Jun; 12():40. PubMed ID: 23764104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatio-temporal pattern, matching level and prediction of ageing and medical resources in China.
    Wang Z; Ye W; Chen X; Li Y; Zhang L; Li F; Yao N; Gao C; Wang P; Yi D; Wu Y
    BMC Public Health; 2023 Jun; 23(1):1155. PubMed ID: 37322467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influence of China's COVID-19 Treatment Policy on the Sustainability of Its Social Health Insurance System.
    Zuo F; Zhai S
    Risk Manag Healthc Policy; 2021; 14():4243-4252. PubMed ID: 34703336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.